ANXA1 is an essential endogenous regulator of BBB integrity in neurodegenerative diseases because it strengthens endothelial tight junction formation through the formyl peptide receptor 2 (FPR2)/RhoA pathway. Here, FPR2 is linked to neurodegenerative disease.